{"meta":{"title":"Hexo","subtitle":null,"description":null,"author":"Hua","url":"https://cpresident.github.io"},"posts":[{"title":"HLA in Myasthenia gravis【稿4】报告","date":"2019-03-01T11:52:09.102Z","path":"p/94c7.html","permalink":"https://cpresident.github.io/p/94c7.html","categories":[],"tags":[]},{"title":"HLA in Myasthenia gravis【稿3】插图及表格","date":"2019-02-07T16:00:00.000Z","path":"p/3563.html","permalink":"https://cpresident.github.io/p/3563.html","categories":[],"tags":[]},{"title":"GCSRT课程","date":"2019-02-04T08:36:25.000Z","path":"p/35ac.html","permalink":"https://cpresident.github.io/p/35ac.html","categories":[],"tags":[]},{"title":"HLA in Myasthenia gravis【稿3】报告","date":"2019-02-04T04:36:25.000Z","path":"p/4e76.html","permalink":"https://cpresident.github.io/p/4e76.html","categories":[],"tags":[]},{"title":"Treg cell的发生发展","date":"2019-02-01T16:00:00.000Z","path":"p/b5c6.html","permalink":"https://cpresident.github.io/p/b5c6.html","categories":[],"tags":[]},{"title":"HLA in Myasthenia gravis 【稿2】 报告","date":"2019-01-21T16:00:00.000Z","path":"p/e83a.html","permalink":"https://cpresident.github.io/p/e83a.html","categories":[],"tags":[]},{"title":"HLA in Myasthenia gravis 【Meta可行性分析】","date":"2019-01-17T16:00:00.000Z","path":"p/2d4a.html","permalink":"https://cpresident.github.io/p/2d4a.html","categories":[],"tags":[]},{"title":"HLA in Myasthenia gravis 【稿1】 报告","date":"2019-01-14T16:00:00.000Z","path":"p/ac35.html","permalink":"https://cpresident.github.io/p/ac35.html","categories":[],"tags":[]},{"title":"HLA and Myasthenia gravis【R环境下Biblioshiny分析报告】","date":"2018-12-30T16:00:00.000Z","path":"p/3d25.html","permalink":"https://cpresident.github.io/p/3d25.html","categories":[],"tags":[]},{"title":"BCR is the New Antibody, TCR is still a T Cell Receptor","date":"2018-12-27T16:00:00.000Z","path":"p/e9d9.html","permalink":"https://cpresident.github.io/p/e9d9.html","categories":[],"tags":[]}]}